Edwards Lifesciences (EW) Capital Expenditures Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.35% |
| Dec 31, 2025 | -2.96% |
| Sep 30, 2025 | -11.06% |
| Jun 30, 2025 | -14.56% |
| Mar 31, 2025 | -7.39% |
| Dec 31, 2024 | -6.98% |
| Sep 30, 2024 | -7.37% |
| Jun 30, 2024 | 5.74% |
| Mar 31, 2024 | 9.12% |
| Dec 31, 2023 | 8.92% |
| Sep 30, 2023 | -8.26% |
| Jun 30, 2023 | -1.93% |
| Mar 31, 2023 | 7.32% |
| Dec 31, 2022 | 5.83% |
| Sep 30, 2022 | 7.21% |
| Jun 30, 2022 | -6.74% |
| Mar 31, 2022 | 41.54% |
| Dec 31, 2021 | -10.50% |
| Sep 30, 2021 | 27.32% |
| Jun 30, 2021 | 13.31% |
| Mar 31, 2021 | 30.79% |
| Dec 31, 2020 | 33.62% |
| Sep 30, 2020 | 12.87% |
| Jun 30, 2020 | 61.61% |
| Mar 31, 2020 | 31.63% |
| Dec 31, 2019 | 139.89% |
| Sep 30, 2019 | 39.71% |
| Jun 30, 2019 | 32.20% |
| Mar 31, 2019 | 24.16% |
| Dec 31, 2018 | 23.44% |
| Sep 30, 2018 | -0.21% |
| Jun 30, 2018 | 83.59% |
| Mar 31, 2018 | 49.94% |
| Dec 31, 2017 | 3.31% |
| Sep 30, 2017 | 10.48% |
| Jun 30, 2017 | 23.58% |
| Mar 31, 2017 | -6.59% |
| Dec 31, 2016 | 42.86% |
| Sep 30, 2016 | -33.95% |
| Jun 30, 2016 | 16.62% |
| Mar 31, 2016 | 14.79% |
| Dec 31, 2015 | -33.93% |
| Sep 30, 2015 | 28.02% |
| Jun 30, 2015 | -22.55% |
| Mar 31, 2015 | 21.06% |
| Dec 31, 2014 | -48.01% |
| Sep 30, 2014 | -31.23% |